Start Date Oct 2021
Many patients with a common liver cancer, hepatocellular carcinoma (HCC), have undiagnosed cirrhosis. These patients have missed the opportunity for surveillance that could detect HCC earlier and improve chances of survival. We have established an accurate cirrhosis detection pathway and aim to examine its effect and cost on early HCC diagnosis and HCC surveillance compared to usual care. 2800 patients will be recruited across rural and urban general practices in Australia for this trial.